Overview

A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY

Status:
Unknown status

Trial end date:
2018-11-01

Target enrollment:

Participant gender:

Summary

This is a randomized controlled trial whose purpose is to evaluate the efficacy of therapy with lactulose and rifaximin associated with a vegetable diet in the prevention of post-TIPS hepatic encephalopathy.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Roma La Sapienza

Treatments:

Rifaximin